SIR-SPHERES MICROSPHERES

FDA Premarket Approval P990065 S010

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for changes in device package insert with insertion of bsa model to replace the current empirical model for calculation of individual required activity dose, change of lung shunt fraction to total lung dose, less than 30 gy to apply in the dose calculation, re-define the radio-embolization induced liver disease (reild) and addition of dose reduction guidance in reild, addition of guidance of lobar therapy using bsa model, and deletion of empirical model and partition model for dose calculation.

DeviceSIR-SPHERES MICROSPHERES
Generic NameMicrospheres Radionuclide
ApplicantSirtex Medical Pty Ltd
Date Received2016-12-19
Decision Date2017-01-18
PMAP990065
SupplementS010
Product CodeNAW 
Advisory CommitteeRadiology
Supplement TypeSpecial (immediate Track)
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address Sirtex Medical Pty Ltd shop 6 207 Pacific Highway st Leonards, New South Wales 2065

Supplemental Filings

Supplement NumberDateSupplement Type
P990065Original Filing
S012 2022-03-21 30-day Notice
S011
S010 2016-12-19 Special (immediate Track)
S009 2016-08-08 Normal 180 Day Track No User Fee
S008 2015-01-15 30-day Notice
S007 2014-09-09 Special (immediate Track)
S006 2011-09-19 Normal 180 Day Track No User Fee
S005
S004 2006-05-15 Normal 180 Day Track No User Fee
S003
S002
S001 2003-03-25 Special (immediate Track)

NIH GUDID Devices

Device IDPMASupp
M425SIRY0010 P990065 006
00850014612146 P990065 015
M425SIRY0010 P990065 015
00850014612030 P990065 015

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.